GGrantIndex
← Leaderboards

Syamal Raychaudhuri

Inbios International, Inc.

$5,908,706
Attributed
$6,649,013
Total exposure
10
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1000K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,649,013 · 10

By mechanism

R44$4,570,070 · 3
R42$700,138 · 1
R41$598,047 · 1
R43$481,174 · 4
N43$299,584 · 1

Top collaborators

Others in their field

Top investigators on “Detection

Research focus

DetectionPoint Of CareDiagnosisLateralAntigensClinical ResearchPrototypeDiagnosis Design /EvaluationSerology /SerodiagnosisDiagnosticDiagnostic TestsGoldSensitivity And SpecificityCommunicable Disease DiagnosisTransmission ProcessSerumTrypanosoma CruziRapid DiagnosisProtozoal AntigenSamplingProteinsCountryEarly DiagnosisAntibodies

Grant awards (16)

Development of Next-gen Chagas DetectTM Plus Rapid test for sensitive and specific diagnosis of Chagas disease$988,977
R44 · FY2025 · AI · contact PI
Development of Next-gen Chagas DetectTM Plus Rapid test for sensitive and specific diagnosis of Chagas disease$999,997
R44 · FY2024 · AI · contact PI
Development of Next-Gen Chagas Detection$299,584
N43 · FY2021 · AI · contact PI
Point-of-care antigen detection assay for early diagnosis of Ebola virus disease (EVD)$298,935
R41 · FY2021 · AI · contact PI
Point-of-care antigen detection assay for early diagnosis of Ebola virus disease (EVD)$299,112
R41 · FY2020 · AI · contact PI
Antigen Detection assay for the Diagnosis of Melioidosis$700,138
R42 · FY2016 · AI · contact PI
Sensitive and Specific Rapid Diagnostic Test for Acute and Chronic Pancreatitis$182,430
R43 · FY2012 · DK · contact PI
Geographically robust rapid assay for T. cruzi infection$459,198
R44 · FY2010 · AI · contact PI
Geographically robust rapid assay for T. cruzi infection$530,883
R44 · FY2009 · AI · contact PI
Geographically robust rapid assay for T. cruzi infection$381,820
R44 · FY2005 · AI
Geographically robust rapid assay for T. cruzi infection$470,363
R44 · FY2004 · AI
New Generation Test for Visceral Leishmaniasis Diagnosis$346,969
R44 · FY2002 · AI
A Novel, Rapid Test for Diagnosis of T.cruzi infection$99,812
R43 · FY2002 · AI
New Generation Test for Visceral Leishmaniasis Diagnosis$391,863
R44 · FY2001 · AI
A NOVEL IMMUNOCHROMATOGRAPHIC DIAGNOSTIC ASSAY FOR TB$99,938
R43 · FY2000 · AI
NEXT GENERATION ASSAY FOR THE DIAGNOSIS OF LEISHMANIASIS$98,994
R43 · FY2000 · AI